Close Menu

NEW YORK (GenomeWeb) – Biocept announced today it has priced a public offering expected to raise approximately $10 million in gross proceeds.

Biocept is offering 9.1 million shares of its common stock, as well as warrants to purchase up to an aggregate of 9.1 million shares at a combined offering price of $1.10 per share. The warrants are exercisable immediately and will expire five years from the date of issuance, the company said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A letter criticizing actions by the US government and research institutions toward Chinese and Chinese-American scientists has garnered more than a hundred signatories.

NPR reports that researchers in New York are investigating whether it is possible to edit the genomes of human sperm.

In an opinion piece at the Nation, Sarah Lawrence College's Laura Hercher argues that everyone should be able to access prenatal genetic testing.

In Nature this week: ancient DNA uncovers presence of Mediterranean migrants at a Himalayan lake, and more.